Abstract Library

#3008 A Single-Center Retrospective Analysis of Thymic Neuroendocrine Tumor

Introduction: Thymic neuroendocrine tumor (NET) is a rare type of tumor located in the anterior mediastinum.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Chen J,

Keywords: thymic neuroendocrine tumor, atypical carcinoid,

#2136 Combination of Capecitabine and Temozolomide for Advanced Thymic Neuroendocrine Tumors

Introduction: In vitro data indicate that the combination of capecitabine(CAP) and temozolomide(TEM) is synergistic for induction of apoptosis in neuroendocrine tumor cell lines. It has been proven that the CAPTEM regimen is associated with an exceptionally high and durable response rate in patients with metastatic pancreatic neuroendocrine tumors. However, there is less evidence to illustrate if the CAPTEM regimen is effective for thymic neuroendorine tumors(TNET).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Tan H

Authors: Wang X, Li Y, Shi Y, Chen Y, Qiu X,

Keywords: thymic neuroendocrine tumors, capecitabine, temozolomide, progress-free survival, adverse effect,

#1318 MEN1 Associated Thymic Neuroendocrine Tumors in Oulu University Hospital Finland

Introduction: Thymic neuroendocrine tumors (TNET) are rare and account 2-5% of all thymic tumors. TNET can occur either sporadically or as a manifestation of an inherited tumor syndrome such as multiple endocrine neoplasia type 1 (MEN1). The prognosis is severe.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Yliaska I

Authors: Yliaska I, Lesonen T, Ebeling T, Koivikko M, Salmela P,

Keywords: thymic neuroendocrine tumor, thymic carcinoid tumor, MEN1,

#449 Effective Treatment of a Metastatic Thymic Neuroendocrine Tumor with Capecitabine and Temozolomide: A Case Report

Introduction: Thymic neuroendocrine tumors are rare, with an estimated annual incidence of 0.2 per million. They are generally considered chemoresistant and there have been no reported cases of an objective response to therapy.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: SarangaPerry V, Morse B, Kvols L, Strosberg J,

Keywords: neuroendocrine tumor, thymus, capecitabine, temozolomide,

#258 Diagnosis and Management of Thymic Neuroendocrine Tumors: A Case Series Review

Introduction: Thymic neuroendocrine tumors (TNET) represent rare types of thymic tumors with an incidence of 0.01/100000 per year. They commonly show rapid disease progression and are rarely curable.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Akay E, El-Khouly F, Khan M, Caplin M, Toumpanakis C,

Keywords: thymic, thymic neuroendocrine tumor, radical thymectomy, chemotherapy, somatostatin analogues, Y-90,